Effects of Sufentanil Preconditioning on Myocardial Infarction Areas and the Myocardial Enzyme in Myocardial Ischemia- Reperfusion Injury in Rats In Vivo

Abstract:

Objective.To investigate the effects of sufentanil preconditioning on Myocardial ischemia reperfusion injury in rats in vivo.Methods. To randomly divide 50 male SD rats equally into 5 groups, including ischemia-reperfusion group( Group I/R ), ischemic preconditioning group(Group IPC), high-dose sufentanil preconditioning group(Group HS, 6.0µg/kg), medium-dose sufentanil preconditioning group(Group MS,2.0µg/kg) and low-dose sufentanil preconditioning group(Group LS, 0.60µg/kg).The left anterior descending coronary arterys(LAD) of rats in five groups are ligated for 30 minutes and are re-perfused for 90 minutes. To measure the myocardial infarction size (IS/AAR%) with double-staining with Even's blue and triphenyltetrazolium chloride, and to calculate the concentration of LK, LK-MB and LDH. Result. Comparing with Group 1/R , the myocardial infarction size(IS/AAR%) in Group IPC, HS, MS and LS all reduced at different levels. Among the Group HS, MS and LS, the infarction size in Group HS reduced most significantly. Comparing with Group 1/R, the concentration of the serum myocardial enzymes in the other four groups all reduced at different levels. Conclusion. Sufentanil preconditioning can reduce myocardial infarct size, decrease the concentration of the serum myocardial enzymes. Therefore, sufentanil preconditioning has protective effects on myocardial ischemia-reperfusion injury in rats in vivo, and the effects are dose-dependent. Suffentanil is a potent kind of opioid analgesics, which is widely used in clinical anesthesia. However, further studies are needed on effects of sufentanil preconditioning on myocardial ischemia reperfusion injury. In order to protect the Myocardial ischemia patients and provide the foundations for application of sufentanil in peri-operative period, the authors investigate the effects of sufentanil preconditioning on myocardial ischemia reperfusion injury through comparison and analysis of the myocardial infarction size(IS), the concentration of the serum myocardial enzymes in the ischemia-reperfusion group(Group IPC), the ischemic preconditioning group(Group IPC) and different-dose sufentanil preconditioning group(Group HS, MS LS).

• Periodical: Advanced Materials Research (Volume 680)
• Pages: 614-616
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.680.614
• Online since: April 2013
• Authors: Ming Gao, Guo Qing Zhao, Jia Wang, Da Peng Gao
• Keywords: Ischemic Preconditioning, Myocardial Ischemia-Reperfusion Injury, Sufentanil

References

[1] Murry CE, Jennings RB, Reimer KA, Preconditioning with ischemia: A delay of lethal cell injury in is chemic myocardia, Circulation, 1986, 74(5, PP. 1124-1136.

DOI: 10.1161/01.cir.74.5.1124

[2] Chen ZL, Li TZ, Zhang BX, Morphine post conditioning protects against re-perfusion injury in the isolated rat hearts[J], Surg Res, 2008, 145, PP. 287-294.

DOI: 10.1016/j.jss.2007.07.020

[3] Zhang Y, Irwin MG, Wong TM: Remifentanil Preconditioning Protects Against Ischemic Injury in the Intact Rat Heart[J]. Anesthesiology, 2004, 101(4), 918.

DOI: 10.1097/00000542-200410000-00017

[4] Tsang A, Hausenloy DJ, Mocanu MM, et al, Postconditioning: a form of modified reperfusion, protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway[J]. Circ Res, 2004, 95(30), PP. 230-232.

DOI: 10.1161/01.res.0000138303.76488.fe

[5] Zhao ZQ, Corvera JS, HAlkos ME, et al., Inhibition of Myocardial Injury by Ischemic Postconditioning during Reperfusion, Comparison with Ischemic Preconditioning, An J circ Physiol, 2003, 285(2), 579.

DOI: 10.1152/ajpheart.01064.2002